Kyphoscoliosis Treatment Market Report 2025

This report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.

The kyphoscoliosis treatment market size has grown strongly in recent years. It will grow from $3.08 billion in 2024 to $3.27 billion in 2025 at a compound annual growth rate (CAGR) of 6.3%. The growth in the historic period can be attributed to exploration of regenerative medicine, genetic research contributions, telemedicine and remote monitoring, advancements in rehabilitation programs.

The kyphoscoliosis treatment market size is expected to see strong growth in the next few years. It will grow to $4.1 billion in 2029 at a compound annual growth rate (CAGR) of 5.8%. The growth in the forecast period can be attributed to personalized treatment approaches, expansion of biomechanical research, remote monitoring and telehealth services, continued genetic research. Major trends in the forecast period include advanced surgical techniques, innovative bracing technologies, customized treatment plans, adoption of 3D printing, pain management innovations.

The growing number of spinal cord injuries is anticipated to drive the expansion of the kyphoscoliosis treatment market. Spinal cord injuries refer to any damage, trauma, or harm to the spine's components, including the vertebrae, intervertebral discs, ligaments, muscles, nerves, and other supportive structures, which can lead to the development of kyphoscoliosis and alterations in spinal alignment. Treating kyphoscoliosis caused by spinal cord injuries involves a holistic approach, including orthopedic evaluation, physical therapy, bracing, possible surgery, pain management, and a multidisciplinary healthcare team focused on patient education and personalized care plans. For example, in February 2022, according to the Alabama Department of Public Health, a US-based state agency, the ATR reported 3,817 neurological injuries involving the head and spinal cord in 2022, compared to 4,734 cases in 2021. As a result, the increasing number of spinal cord injuries is fueling the growth of the kyphoscoliosis treatment market.

The rise in telemedicine usage is expected to further drive the growth of the kyphoscoliosis treatment market. Telemedicine refers to healthcare services delivered remotely through telecommunications technologies, such as videoconferencing, phone calls, and digital messaging. It enables patients to consult with orthopedic specialists and spine surgeons without needing to travel to healthcare facilities, which is particularly beneficial for individuals with kyphoscoliosis who may face physical challenges. For example, in February 2023, Rock Health, a US-based non-profit, reported that 80% of survey respondents had used telemedicine at some point in 2022, up from 72% in 2021. Thus, the increased use of telemedicine is contributing to the growth of the healthcare transportation service market.

The increasing incidence of genetic disorders is expected to be a significant catalyst for the growth of the kyphoscoliosis treatment market. Genetic disorders, stemming from abnormalities or mutations in an individual's DNA, often involve spinal curvature abnormalities requiring kyphoscoliosis treatment. The prevalence of genetic conditions in children is estimated to be 1 in 25 in the UK, affecting over 2.4 million individuals. The multidisciplinary treatment approach, encompassing various strategies such as beta-blocker therapy, physical therapy, and orthopedic surgeon supervision, underlines the pivotal role of kyphoscoliosis treatment in managing genetic disorders and contributes to market growth.

Leading companies in the kyphoscoliosis treatment market are developing innovative products, such as the MARVEL Growing Rod System, specifically designed for early-onset scoliosis. The MARVEL Growing Rod System is a posterior stabilizing rod that can be surgically implanted and periodically lengthened through hand-operated mechanical actuation. For example, in July 2023, Globus Medical Inc., a US-based medical device company, launched the MARVEL Growing Rod System. It is designed to assist patients under 10 years old with early-onset scoliosis in achieving and maintaining spinal correction while allowing for continued growth through minimally invasive distraction. The system offers significant distraction, immediate tactile feedback, and automated locking, ensuring reliable growth. This innovative product, the Growing Rod System, is expected to contribute to the future growth of the market.

Major companies operating in the kyphoscoliosis treatment market report are Johnson & Johnson Services Inc., Aspen Medical Products LLC, Medtronic PLC, Stryker Corporation, Milwaukee Brace Company, Zimmer Biomet Holdings Inc., Perrigo Company PLC, Teva Pharmaceuticals Inc., B. Braun Melsungen Aktiengesellschaft, Aurobindo Pharma Limited, Integra LifeSciences Ltd., NuVasive Inc., DJO Global Inc., Globus Medical Inc., Boston Orthotics & Prosthetics, Ossur hf., Aesculap Inc., DeRoyal Industries Inc., MicroPort Scientific Corp., Alphatec Holdings Inc., Trulife Ltd., Ottobock SE & Co. KGaA, Orthofix Holdings Inc., OrthoPediatrics Corp., Proteor S.A., Orthomerica Products Inc., Breg Inc., Innomed Inc., Restorative Care of America Inc., Spinal Elements Inc.

North America was the largest region in the kyphoscoliosis treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the kyphoscoliosis treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the kyphoscoliosis treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The kyphoscoliosis treatment market consists of revenues earned by entities by providing services such as physical therapy, pain management, specialist psychological support, and medical evaluation. The market value includes the value of related goods sold by the service provider or included within the service offering. The kyphoscoliosis treatment market also includes sales of lumbar support cushions, orthopedic braces, back support belts, and exercise and therapy equipment. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

Kyphoscoliosis is a spinal condition characterized by abnormal forward curvature (kyphosis) and sideways curvature (scoliosis) of the spine, leading to postural and respiratory problems. The treatment involves medical interventions and therapies aimed at managing and correcting the spinal deformity, improving posture, reducing pain, and preventing further spinal curvature.

The main types of kyphoscoliosis include postural kyphosis, Scheuermann’s kyphosis, congenital kyphosis, and kyphoscoliosis. Postural kyphosis refers to the rounding or hunching of the back, typically affecting teenagers and young adults. Treatment options for kyphoscoliosis encompass medications, surgery, and bracing, and these are implemented by hospitals, clinics, and ambulatory surgical centers.

The kyphoscoliosis treatment market research report is one of a series of new reports that provides kyphoscoliosis treatment market statistics, including kyphoscoliosis treatment industry global market size, regional shares, competitors with a kyphoscoliosis treatment market share, detailed kyphoscoliosis treatment market segments, market trends and opportunities, and any further data you may need to thrive in the kyphoscoliosis treatment industry. This kyphoscoliosis treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.